Add like
Add dislike
Add to saved papers

Size-Dependent Catalytic Activity of Monodispersed Nickel Nanoparticles for the Hydrolytic Dehydrogenation of Ammonia Borane.

Nickel (Ni) nanoparticles (NPs) with controlled sizes in the range of 4.9-27.4 nm are synthesized by tuning the ratio of the nickel acetylacetonate precursor and trioctylphosphine in the presence of oleylamine. X-ray diffraction and transmission electron microscopy confirm the formation of the metallic Ni crystal phase and their monodispersed nature. These Ni NPs are found to be effective catalysts for the hydrolytic dehydrogenation of ammonia borane, and their catalytic activities are size-dependent. A volcano-type activity trend is observed with 8.9 nm Ni NPs presenting the best catalytic performance. The activation energy and turnover frequency (TOF) of the 8.9 nm NP catalyst are further calculated to be 66.6 kJ·mol-1 and 154.2 molH2 ·molNi -1 ·h-1 , respectively. Characterization of the spent catalysts indicates that smaller-sized NPs face severe agglomeration, resulting in poor stability and activity. Three carbon support materials are thus used to disperse and stabilize the Ni NPs. It shows that 8.9 nm Ni NPs supported on Ketjenblack (KB) exhibit higher activity than that supported on carbon nanotubes and graphene nanoplatelets. The agglomeration-induced activity loss is further illustrated by immobilizing 4.9 nm Ni NPs onto KB, which exhibits significantly enhanced activity with a high TOF of 447.9 molH2 ·molNi -1 ·h-1 as well as an excellent reusability in the consecutive dehydrogenation of ammonia borane. The high catalytic performance can be attributed to the intrinsic activity of nanoparticulate Ni and the improved activity and stability due to the strong Ni/KB metal-support interactions.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app